AtriCure to Announce First Quarter 2025 Financial Results
08 4월 2025 - 9:00PM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments and therapies for atrial fibrillation (Afib), left
atrial appendage (LAA) management, and post-operative pain
management, today announced that it will release its first quarter
2025 financial results on Tuesday, April 29, 2025.
AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on
Tuesday, April 29, 2025, to discuss its first quarter 2025
financial results. Those interested in listening to the conference
call should register online using this link. Participants are
encouraged to register more than 15 minutes before the start of the
call. A live and replay version of the audio webcast will be
available at
https://ir.atricure.com/events-and-presentations/events.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 59
million people worldwide. Electrophysiologists, cardiothoracic and
thoracic surgeons around the globe use AtriCure technologies for
the treatment of Afib, reduction of Afib related complications and
post-operative pain management. AtriCure’s Isolator® Synergy™
Ablation System is the first medical device to receive FDA approval
for the treatment of persistent Afib. AtriCure’s AtriClip® Left
Atrial Appendage Exclusion System products are the most widely sold
LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is
a minimally invasive procedure that provides a lasting solution for
long-standing persistent Afib patients. AtriCure’s cryoICE
cryoSPHERE® probes are cleared for temporary ablation of peripheral
nerves to block pain, providing pain relief in cardiac and thoracic
procedures. For more information, visit AtriCure.com or follow us
on X (formerly Twitter) @AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250408374450/en/
Angie Wirick AtriCure, Inc. Chief Financial Officer (513)
755-5334 awirick@atricure.com
Marissa Bych Gilmartin Group Investor Relations marissa@gilmartinir.com
AtriCure (NASDAQ:ATRC)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
AtriCure (NASDAQ:ATRC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025
